Test bank for Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition by Nader Rifai, PhD Chapters 1 - 49

Test bank for Tietz Fundamentals of Clinical Chemistry
cc cc cc cc cc cc cc




and Molecular Diagnostics 8th Edition
cc cc cc c c




cc by Nader Rifai, PhD Chapters 1 - 49
cc cc cc c c cc cc cc

,cc




Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
cc cc cc cc cc cc cc cc
cc
cc cc




Table of contents: cc cc




I. Principles Of Laboratory Medicine
cc cc cc cc




Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
cc cc cc cc cc cc cc cc




Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
cc cc cc cc cc cc cc cc cc cc cc




Chapter 3. Clinical Evaluation of Methods
cc cc cc cc cc




Chapter 4. Evidence-Based Laboratory Medicine
cc cc cc cc




Chapter 5. Establishment and Use of Reference Values
cc cc cc cc cc cc cc




Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
cc cc cc cc cc cc cc cc




Chapter 7. Quality Management
cc cc cc




II. Analytical Techniques And Instrumentation
cc cc cc cc




Chapter 8. Principles of Basic Techniques and Laboratory Safety
cc cc cc cc cc cc cc cc




Chapter 9. Optical Techniques
cc cc cc




Chapter 10. Electrochemistry and Chemical Sensors
cc cc cc cc cc




Chapter 11. Electrophoresis
cc cc




Chapter 12. Chromatographycc cc




Chapter 13. Mass Spectrometry
cc cc cc




Chapter 14. Enzyme and Rate Analyses
cc cc cc cc cc




Chapter 15. Immunochemical Techniques
cc cc cc




Chapter 16 Automation cc cc




Chapter 17. Point-of-Care Instrumentation
cc cc cc




III. Analytes
cc cc




Chapter 18. Amino Acids, Peptides, and Proteins
cc cc cc cc cc cc




Chapter 19. Serum Enzymes cc cc cc




Chapter 20. Tumor Markers and Cancer Genes
cc cc cc cc cc cc




Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
cc cc cc cc cc cc cc cc cc cc cc




Chapter 22. Carbohydrates cc cc




Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
cc cc cc cc cc cc cc cc cc




Chapter 24. Electrolytes and Blood Gases
cc cc cc cc cc




Chapter 25. Hormones cc cc




Chapter 26. Catecholamines and Serotonin
cc c c cc cc




Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
cc cc cc cc cc cc cc




Chapter 28. Hemoglobin, Iron, and Bilirubin
cc cc cc cc cc




Chapter 29. Porphyrins and Porphyrias
cc cc cc cc




Chapter 30. Therapeutic Drugs and Their Management
cc cc cc cc cc cc




Chapter 31. Clinical Toxicology
cc cc cc




Chapter 32. Toxic Metals cc c c cc




IV. Pathophysiology
cc cc




Chapter 33. Diabetes cc cc

,Chapter 34. Cardiovascular Disease
cc c c cc




Chapter 35. Kidney Disease
cc cc cc




Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
cc c c cc cc cc cc cc cc cc cc




Chapter 37. Liver Disease
cc cc cc cc




Chapter 38. Gastrointestinal and Pancreatic Diseases
cc c c cc cc cc




Chapter 39. Disorders of Bone and Mineral Metabolism
cc cc cc cc cc cc cc cc




Chapter 40. Disorders of the Pituitary Gland
cc cc cc cc cc cc cc




Chapter 41. Disorders of the Adrenal Cortex
cc c c cc cc cc cc




Chapter 42. Thyroid Disorders
cc c c cc




Chapter 43. Reproduction-Related Disorders
cc c c cc




Chapter 44. Pregnancy and Prenatal Testing
cc cc cc cc cc cc




Chapter 45. Newborn Screening and Inborn Errors of Metabolism
cc c c cc cc cc cc cc cc




Chapter 46. Pharmacogenetics
cc cc




V. Molecular Diagnostics
cc cc cc




Chapter 47. Principles of Molecular Biology
cc cc cc cc cc




Chapter 48. Nucleic Acid Techniques and Applications
cc cc cc cc cc cc




Chapter 49. Genomes and Nucleic Acid Alterations
cc cc cc cc cc cc

, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
cc cc cc cc cc cc cc cc cc




cc
TO GET ALL CHAPTERS EMAIL ME AT>>>>>
cc cc cc cc cc cc cc cc cc




cc



Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
cc cc cc cc cc cc cc cc



cTestBank
c




MULTIPLE CHOICE cc




1. An individual working in a clinical chemistry laboratory is married to a sales representative
cc cc cc cc cc cc cc cc cc cc cc cc cc



c who works for a company that sells chemistry laboratory supplies. When the laboratory
c cc cc cc cc cc cc cc cc cc cc cc cc



c manager requests a list of needed supplies, cost of supplies, and vendors, this individual only
c cc cc cc cc cc cc cc cc cc cc cc cc cc cc



recommends the spouse’s company as the vendor. This is considered to be a(n):
c c cc cc cc cc cc cc cc cc cc cc cc cc



a. accounting issue. cc



b. possible conflict of interest. cc cc cc



c. maintenance of confidentiality issue. cc cc cc



d. problem with resource allocation. cc cc cc




ANS: B cc



Concern has been raised over the interrelationships between practitioners in the medical field
cc cc cc cc cc cc cc cc cc cc cc cc



c and commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
c cc cc cc cc cc cc cc cc cc cc cc



Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers
cc cc cc cc cc cc cc cc c c



and providers of diagnostic equipment and supplies. These concerns led the National
cc cc cc cc cc cc cc cc cc cc cc c c



Institutes of Health (NIH) in 1995 to require official institutional review of financial disclosure
cc cc cc cc cc cc cc cc cc cc cc cc cc c c



by researchers and management of situations in which disclosure indicates potential conflicts of
cc cc cc cc cc cc cc cc cc cc cc c c cc



interest.
cc




DIF: 1 REF: Page 4-5 cc cc cc cc OBJ: 6 | 7 cc cc cc




2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
cc cc cc cc cc cc cc cc cc cc cc cc cc cc



c the pain following her recent surgery. A friend of the patient claims that the same painkiller
c cc cc cc cc cc cc cc cc cc cc cc cc cc cc cc



c ―worked wonders‖ to reduce her pain after the same surgery. The physician states that the
c cc cc cc cc cc cc cc cc cc cc cc cc cc cc



c difference in the effect of the drug might be caused by
c , which is studied in
cc cc cc cc cc cc cc cc cc cc cc cc cc cc



pharmacogenetics.
c c



a. epidemiology
b. an inherited disease cc cc



c. a conflict of interest cc cc cc



d. a genetic variation in drug-metabolizing enzymes
cc cc cc cc cc




ANS: D cc



Pharmacogenetics is the study of the genetic variation of drug metabolism between cc cc cc cc cc cc cc cc cc cc cc



cindividuals.
c




DIF: 1 REF: Page 3 cc cc c c cc OBJ: 1 cc




3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
cc cc cc cc cc cc cc cc cc cc cc cc cc cc



c c name of a close friend printed on the bar-coded label. The genetic test that is ordered on the
cc cc cc cc cc cc cc cc cc cc cc cc cc cc cc cc cc



c c friend’s sample would provide diagnostic information about a disorder that has a poor
cc cc cc cc cc cc cc cc cc cc cc cc



c c prognosis, and the test is usually performed by John. He asks a fellow employee to analyze
cc cc cc cc cc cc cc cc cc cc cc cc cc cc cc



c c the sample for him and not divulge the results. This ethical issue concerns:
cc cc cc cc cc cc cc cc cc cc cc cc